PAULA SANDERLIN: Open Payments
NPI 1871113969 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 54 payments from 13 companies in 2025. Trend: 2023 $2,440 · 2024 $2,183 · 2025 $854
Food & beverage: $776Education: $78
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 27 | $301 |
| Janssen Biotech, Inc. | 4 | $130 |
| ABBVIE INC. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| UCB, Inc. | 2 | $57 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $18 |
Products named: TREMFYA, OTEZLA, TAVNEOS, COSENTYX, EVENITY, Bimzelx, ACTHAR, RINVOQ.
Industry payments across ID — which companies pay providers there.
